Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer

Carcinogenesis

Volumn 27, Issue 7, 2006, Pages 1341-1348

  Ai, Lingbao ^b   Tao, Qian ^a   Zhong, Sheng ^b   Fields, C Robert ^b   Kim, Wan Ju ^b   Lee, Michael W ^b   Cui, Yan ^a   Brown, Kevin D ^b   Robertson, Keith D ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BISULFITE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3B; WNT1 PROTEIN;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; GENE ACTIVITY; GENE EXPRESSION; GENE SEQUENCE; GENE SILENCING; GENE TARGETING; GENETIC ASSOCIATION; GENETIC CODE; HUMAN; HUMAN CELL CULTURE; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; CARRIER PROTEINS; CELL LINE, TUMOR; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DOWN-REGULATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; MALE; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33745634864     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi379     Document Type: Article

References (48)

1. Weinberg,R.A. (1996) How cancer arises. Sci. Am., 275, 62-70.
2. Nusse,R. and Varmus,H.E. (1982) Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell, 31, 99-109.
3. Logan,C.Y. and Nusse,R. (2004) The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol., 20, 781-810.
4. He,T.C., Sparks,A.B., Rago,C., Hermeking,H., Zawel,L., da Costa,L.T., Morin,P.J., Vogelstein,B. and Kinzler,K.W. (1998) Identification of c-MYC as a target of the APC pathway. Science, 281, 1509-1512.
5. Pelengaris,S., Khan,M. and Evan,G. (2002) c-MYC: More than just a matter of life and death. Nat. Rev. Cancer, 2, 764-776.
6. Adhikary,S. and Eilers,M. (2005) Transcriptional regulation and transformation by Myc proteins. Nat. Rev. Mol. Cell Biol., 6, 635-645.
7. Wu,K.J., Grandori,C., Amacker,M., Simon-Vermot,N., Polack,A., Lingner,J. and Dalla-Favera,R. (1999) Direct activation of TERT transcription by c-MYC. Nat. Genet, 21, 220-224.
8. Maser,R.S. and DePinho,R.A. (2002) Connecting chromosomes, crisis, and cancer. Science, 297, 565-569.
9. Polakis,P. (2000) Wnt signaling and cancer. Genes Dev., 14, 1837-1851.
10. Li,Y., Hively,W.P. and Varmus,H.E. (2000) Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer. Oncogene, 19, 1002-1009.
11. Michaelson,J.S. and Leder,P. (2001) Beta-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland. Oncogene, 20, 5093-5099.
12. Lin,S.Y., Xia,W., Wang,J.C., Kwong,K.Y., Spohn,B., Wen,Y., Pestell,R.G. and Hung,M.C. (2000) Beta-catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression. Proc. Natl Acad. Sci. USA, 97, 4262-4266.
13. Ozaki,S., Ikeda,S., Ishizaki,Y., Kurihara,T., Tokumoto,N., Iseki,M., Arihiro,K., Kataoka,T., Okajima,M. and Asahara,T. (2005) Alterations and correlations of the components in the Wnt signaling pathway and its target genes in breast cancer. Oncol. Rep., 14, 1437-1443.
14. Hsieh,J.C., Kodjabachian,L., Rebbert,M.L., Rattner,A., Smallwood,P.M., Samos,C.H., Nusse,R., Dawid,I.B. and Nathans,J. (1999) A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature, 398, 431-436.
15. Mazieres,J., He,B., You,L., Xu,Z., Lee,A.Y., Mikami,I., Reguart,N., Rosell,R., McCormick,F. and Jablons,D.M. (2004) Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer. Cancer Res., 64, 4717-4720.
16. Taniguchi,H., Yamamoto,H., Hirata,T., Miyamoto,N., Oki,M., Nosho,K., Adachi,Y., Endo,T., Imai,K. and Shinomura,Y. (2005) Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers. Oncogene, 24, 7946-7952.
17. Wissmann,C., Wild,P.J., Kaiser,S. et al. (2003) WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer. J. Pathol., 201, 204-212.
18. Jones,P.A. and Baylin,S.B. (2002) The fundamental role of epigenetic events in cancer. Nat. Rev. Genet., 3, 415-428.
19. Dobrovic,A. and Simpfendorfer,D. (1997) Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res., 57, 3347-3350.
20. Esteller,M., Silva,J.M., Dominguez,G. et al. (2000) Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J. Natl Cancer Inst., 92, 564-569.
21. Ferguson,A.T., Evron,E., Umbricht,C.B. et al. (2000) High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. Proc. Natl Acad. Sci. USA, 97, 6049-6054.
22. Nass,S.J., Herman,J.G., Gabrielson,E., Iversen,P.W., Parl,F.F., Davidson,N.E. and Graff,J.R. (2000) Aberrant methylation of the estrogen receptor and E-cadherin 5′ CpG islands increases with malignant progression in human breast cancer. Cancer Res., 60, 4346-4348.
23. Holst,C.R., Nuovo,G.J., Esteller,M., Chew,K., Baylin,S.B., Herman,J.G. and Tlsty,T.D. (2003) Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia. Cancer Res., 63, 1596-1601.
24. Vo,Q.N., Kim,W.J., Cvitanovic,L., Boudreau,D.A., Ginzinger,D.G. and Brown,K.D. (2004) The ATM gene is a target for epigenetic silencing in locally advanced breast cancer. Oncogene, 23, 9432-9437.
25. Rhee,I., Bachman,K.E., Park,B.H. et al. (2002) DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature, 416, 552-556.
26. Qiu,G.H., Tan,L.K., Loh,K.S., Lim,C.Y., Srivastava,G., Tsai,S.T., Tsao,S.W. and Tao,Q. (2004) The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma. Oncogene, 23, 4793-4806.
27. Herman,J.G., Graff,J.R., Myohanen,S., Nelkin,B.D. and Baylin,S.B. (1996) Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc. Natl Acad. Sci. USA, 93, 9821-9826.
28. Frommer,M., McDonald,L.E., Millar,D.S., Collis,C.M., Watt,F., Grigg,G.W., Molloy,P.L. and Paul,C.L. (1992) A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl Acad. Sci. USA, 89, 1827-1831.
29. Macleod,D., Charlton,J., Mullins,J. and Bird,A.P. (1994) Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev., 8, 2282-2292.
30. Hu,M., Yao,J., Cai,L., Bachman,K.E., van den Brule,F., Velculescu,V. and Polyak,K. (2005) Distinct epigenetic changes in the stromal cells of breast cancers. Nat. Genet., 37, 899-905.
31. Agoston,A.T., Argani,P., Yegnasubramanian,S., DeMarzo,A., Ansari-Lari,M.A., Hicks,J.L., Davidson,N.E. and Nelson,W.G. (2005) Increased protein stability causes DNA methyltransferase 1 dysregulation in breast cancer. J. Biol. Chem., 280, 18302-18310.
32. Robertson,K.D., Uzvolgyi,E., Liang,G., Talmadge,C., Sumegi,J., Gonzales,F.A. and Jones,P.A. (1999) The human DNA methyltransferases (DNMTs) 1, 3a, and 3b: Coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res., 27, 2291-2298.
33. Rhee,I., Bachman,K.E., Park,B.H. et al. (2002) DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature, 416, 552-556.
34. Esteller,M. (2005) Aberrant DNA methylation as a cancer-inducing mechanism. Annu. Rev. Pharmacol. Toxicol., 45, 629-656.
35. Glinka,A., Wu,W., Delius,H., Monaghan,A.P., Blumenstock,C. and Niehrs,C. (1998) Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature, 391, 357-362.
36. Leyns,L., Bouwmeester,T., Kim,S.H., Piccolo,S. and De Robertis,E.M. (1997) Frzb-1 is a secreted antagonist of Wnt signaling expressed in the Spemann organizer. Cell, 88, 747-756.
37. Wang,S., Krinks,M., Lin,K., Luyten,F.P. and Moos,M., Jr (1997) Frzb, a secreted protein expressed in the Spemann organizer, binds and inhibits Wnt-8. Cell, 88, 757-766.
38. Liu,T.-H., Raval,A., Chen,S.-S., Matkovic,J.J., Byrd,J.C. and Plass,C. (2006) CpG island methylation and expression of the secreted frizzled-related protein gene family in chronic lymphocytic leukemia. Cancer Res., 66, 653-658.
39. Fukui,T., Kondo,M., Ito,G., Maeda,O., Sato,N., Yoshioka,H., Yokoi,K., Ueda,Y., Shimokata,K. and Sekido,Y. (2005) Transcriptional silencing of secreted frizzled related protein 1 (SFRP1) by promoter hypermethylation in non-small-cell lung cancer. Oncogene, 24, 6323-6327.
40. He,B., Lee,A.Y., Dadfarmay,S., You,L., Xu,Z., Reguart,N., Mazieres,J., Mikami,I., McCormick,F. and Jablons,D.M. (2005) Secreted frizzled-related protein 4 is silenced by hypermethylation and induces apoptosis in beta-catenin-deficient human mesothelioma cells. Cancer Res., 65, 743-748.
41. Lo,P.K., Mehrotra,J., D'Costa,A., Fackler,M.J., Garrett-Mayer,E., Argani,P. and Sukumar,S. (2006) Epigenetic suppression of secreted frizzled related protein 1 (SFRP1) expression in human breast cancer. Cancer Biol. Ther., 5, [Epub] ahead of print] PMID: 16410723.
42. Gillett,C., Smith,P., Gregory,W., Richards,M., Millis,R., Peters,G. and Barnes,D. (1996) Cyclin D1 and prognosis in human breast cancer. Int. J. Cancer, 69, 92-99.
43. Zhang,S.Y., Caamano,J., Cooper,F., Guo,X. and Klein-Szanto,A.J. (1994) Immunohistochemistry of cyclin D1 in human breast cancer. Am. J. Clin. Pathol., 102, 695-698.
44. Gillett,C.E., Lee,A.H., Millis,R.R. and Barnes,D.M. (1998) Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia. J. Pathol., 184, 396-400.
45. Yashima,K., Milchgrub,S., Gollahon,L.S., Maitra,A., Saboorian,M.H., Shay,J.W. and Gazdar,A.F. (1998) Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma. Clin. Cancer Res., 4, 229-234.
46. Hermann,A., Goyal,R. and Jeltsch,A. (2004) The Dnmt1 DNA-(cytosine-C5)-methyltransferase methylates DNA processively with high preference for hemimethylated target sites. J. Biol. Chem., 279, 48350-48359.
47. Liang,G., Chan,M.F., Tomigahara,Y., Tsai,Y.C., Gonzales,F.A., Li,E., Laird,P.W. and Jones,P.A. (2002) Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements. Mol. Cell. Biol., 22, 480-491.
48. Jackson,M., Krassowska,A., Gilbert,N., Chevassut,T., Forrester,L., Ansell,J. and Ramsahoye,B. (2004) Severe global DNA hypomethylation blocks differentiation and induces hyperacetylation in embryonic stem cells. Mol. Cell. Biol., 24, 8862-8871.